Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $4.2K | $0 | $0 | $0 | $0 | −$64.1K | −$159.2K |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $4.2K | $0 | $0 | $0 | $0 | −$64.1K | −$159.2K |
| Gross margin | 100.0% | — | — | — | — | 100.0% | 100.0% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$291.8K | $514.4K | $320.1K | −$734.5K | −$172.4K | −$40.7K | $3.2K |
| EBITDA | −$296.0K | $303.4K | $320.1K | −$734.5K | −$172.4K | −$40.7K | $3.2K |
| Net income | −$291.8K | $514.4K | $320.1K | −$734.5K | −$172.4K | −$40.7K | $3.2K |
| Net margin | -6907.0% | — | — | — | — | 63.6% | -2.0% |
| EPS (diluted) | -0.08 | 0.13 | 0.08 | -0.20 | -0.05 | -0.01 | 0.00 |
Annual figures · source: Financial Modeling Prep
NEVARO CAPITAL
No one on the platform currently holds NVPLF.
No tracked institution reports a position in NVPLF as of their last filing.
No one on the platform has traded NVPLF yet.
| $518 |
| — |
| GFCJGuaranty Financial Corporation | $0.00 | +0.00% | $560 | — |
| LXGTFLexington Biosciences, Inc. | $0.00 | +0.00% | $379 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.